Prestige Consumer Healthcare (PBH) Non-Current Deferred Tax Liability (2011 - 2025)

Prestige Consumer Healthcare's Non-Current Deferred Tax Liability history runs 15 years deep, the most recent figure standing at $449.3 million for Q4 2025.

• On a quarterly basis, Non-Current Deferred Tax Liability rose 8.72% year-over-year to $449.3 million in Q4 2025; TTM through Dec 2025 was $449.3 million, a 8.72% increase from a year earlier, with the FY2025 full-year figure at $419.6 million, up 3.96% from the prior year.
• Non-Current Deferred Tax Liability grew to $449.3 million in Q4 2025 per PBH's latest filing, from $444.9 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $455.8 million in Q4 2022 and bottomed at $384.0 million in Q2 2023.
• The 5-year median for Non-Current Deferred Tax Liability is $430.5 million (2021), against an average of $425.9 million.
• Across the five-year window, Non-Current Deferred Tax Liability dropped 13.24% in 2023 and rose 8.72% in 2025, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $444.8 million in 2021, then climbed by 2.48% to $455.8 million in 2022, then slipped by 12.87% to $397.1 million in 2023, then rose by 4.06% to $413.3 million in 2024, then gained by 8.72% to $449.3 million in 2025.
• Per Business Quant, the three latest PBH Non-Current Deferred Tax Liability figures stand at $449.3 million (Q4 2025), $444.9 million (Q3 2025), and $426.9 million (Q2 2025).